US markets continued to rally (24/08/2020) with the S&P 500 and Nasdaq again setting new highs. The market has enthusiastically welcomed the FDA’s decision to approve the use of blood plasma as a cure for Covid-19 patients.
From the domestic market, JCI today has the opportunity to continue yesterday’s slight strengthening in line with the increases experienced by almost all global exchanges. The JCI has also received positive wind from the Covid-19 vaccine distribution agreement that has been signed with the Chinese side.
Download full report HERE.